secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001437749-24-016762
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo reports record Q1 revenue, positive operating cash flow of $481K
-------------------------------------------------------------------------

- Q1 2024 revenue $4.76M, up 28% YoY and 9% QoQ; generated $481K positive operating cash flow.
- Net loss $775K including $623K non-cash equity comp; stockholder's equity rose from $4.2M to $5.1M.
- Launched water equipment subsidiary for PFAS treatment; appointed Sally Gutierrez, Jeffrey Kightlinger, Larry Dick to board.
- EPA finalized PFAS regulations expected to favor BioLargo's treatment technology due to high efficacy and low waste.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774924016762/0001437749-24-016762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774924016762/blgo20240514_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-016762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer